<?xml version='1.0' encoding='utf8' standalone='yes'?>
<collection><document><id>7323243</id><passage><infon key="name_3">surname:Zhou;given-names:Xiaofang</infon><infon key="name_2">surname:Mou;given-names:Tangwei</infon><infon key="name_1">surname:Li;given-names:Xueqi</infon><infon key="article-id_pmid">32558946</infon><infon key="name_0">surname:Liao;given-names:Yun</infon><infon key="year">2020</infon><infon key="article-id_pmc">7323243</infon><infon key="article-id_publisher-id">JMV26200</infon><infon key="fn">This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/jmv.26200</infon><infon key="article-id_doi">10.1002/jmv.26200</infon><infon key="type">front</infon><infon key="section_type">TITLE</infon><infon key="journal">J. Med. Virol.; 2020 Jun 19 . doi:10.1002/jmv.26200</infon><infon key="alt-title">LIAO et al.</infon><infon key="elocation-id">10.1002/jmv.26200</infon><infon key="license">This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</infon><infon key="name_10">surname:Liang;given-names:Yan</infon><infon key="name_13">surname:Xu;given-names:Xingli</infon><infon key="name_14">surname:Xie;given-names:Zhongping</infon><infon key="name_11">surname:Jiang;given-names:Guorun</infon><infon key="name_12">surname:Fan;given-names:Shengtao</infon><infon key="name_17">surname:Li;given-names:Qihan</infon><infon key="kwd">ACE2 human bronchial epithelial cell line (16HBE) IL-22 SARS-CoV-2 (COVID-19)</infon><infon key="name_15">surname:Chen;given-names:Hongbo</infon><infon key="name_9">surname:Guo;given-names:Lei</infon><infon key="name_16">surname:Liu;given-names:Longding</infon><infon key="name_8">surname:Zheng;given-names:Huiwen</infon><infon key="name_7">surname:dong;given-names:Xingqi</infon><infon key="name_6">surname:Zhang;given-names:Ying</infon><infon key="name_5">surname:Wang;given-names:Lichun</infon><infon key="name_4">surname:Li;given-names:Dandan</infon><infon key="authors">Liao Y, Li X, Mou T, Zhou X, Li D, Wang L, Zhang Y, Dong X, Zheng H, Guo L, Liang Y, Jiang G, Fan S, Xu X, Xie Z, Chen H, Liu L, Li Q, </infon><offset>0</offset><text>Distinct infection process of SARS-CoV-2 in human bronchial epithelial cells line</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>86</offset><text>Abstract</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>95</offset><text>COVID-19, caused by SARS-CoV-2, leads to a series of clinical symptoms of respiratory and pulmonary inflammatory reactions via unknown pathologic mechanisms related to the viral infection process in tracheal or bronchial epithelial cells. Investigation of this viral infection in the human bronchial epithelial cell line (16HBE) suggests that SARS-CoV-2 can enter these cells through interaction between its membrane-localized S protein with the ACE2 molecule on the host cell membrane. Further observation indicates distinct viral replication with a dynamic and moderate increase, whereby viral replication does not lead to a specific cytopathic effect but maintains a continuous release of progeny virions from infected cells. Although mRNA expression of various innate immune signaling molecules is altered in the cells, transcription of IFNalpha, IFNbeta and IFNgamma is unchanged. Furthermore, expression of some interleukins related to inflammatory reactions, such as IL-6, IL-2 and IL-8, is maintained at low levels, whereas that of interleukins involved in immune regulation is upregulated. Interestingly, IL-22, an interleukin that functions mainly in tissue repair, shows very high expression. Collectively, these data suggest a distinct infection process for this virus in respiratory epithelial cells, which may be linked to its clinicopathological mechanism.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1479</offset><text>This article is protected by copyright. All rights reserved.</text></passage></document>
</collection>